Focus on Therapeutic Options for Surgically Resectable Pancreatic Adenocarcinoma Based on Novel Biomarkers.
Curr Oncol
; 30(7): 6462-6472, 2023 07 06.
Article
in En
| MEDLINE
| ID: mdl-37504335
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pancreatic Neoplasms
/
Adenocarcinoma
/
Carcinoma, Pancreatic Ductal
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Curr Oncol
Year:
2023
Document type:
Article
Affiliation country:
Italy
Country of publication:
Switzerland